Webinar

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Published

Format: External webinar | Document type: Webinar

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Related categories: Supply chain, logistics

Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking part in a trial by the need for frequent travel to a clinical sites and around 30% of patients drop out before study completion, leading to data loss, and potential approval delays.

The new model for Direct to/from Patient and home health care allows visits to be conducted in a patient’s home which improves engagement.

Featured speakers will explore the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor, and how homecare can make a difference to patients’ ongoing participation, quality of life and comfort throughout the trial.

For more information visit www.marken.com

Watch Now

Speakers

Kimberly Finn Kimberly Finn VP Global Homecare & DTP US Services
Marken

Paddy Hanlon Paddy Hanlon VP Global Key Accounts
Marken

Jennifer Fenwick Jennifer Fenwick Director, Project Management, Americas
Marken

Latest content from Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Content provided by Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Virtual and hybrid clinical trials have arrived. Having learnt from pilot projects, pharma companies are systematically incorporating patient-centric services into trials, resulting in a significant minority of today’s studies featuring virtual elements....

Related resources from Marken: Global Life Science Supply Chain Solutions

Show more

Supplier info centre